Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Antimicrobial susceptibility patterns and MICs among non-photochromogenic rapidly growing Mycobacteroides and Mycolicibacterium species.

Yoshida S, Tsuyuguchi K, Chikamatsu K, Aono A, Takaki A, Mitarai S, Kobayashi T, Inoue Y, Suzuki K.

J Med Microbiol. 2019 Jul 8. doi: 10.1099/jmm.0.001035. [Epub ahead of print]

PMID:
31282855
2.

Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis.

Tsurumaki H, Matsuyama T, Ezawa K, Koga Y, Yatomi M, Aoki-Saito H, Chikamatsu K, Hisada T.

Medicina (Kaunas). 2019 Jul 3;55(7). pii: E336. doi: 10.3390/medicina55070336.

3.

Immunological and Clinicopathological Significance of MFG-E8 Expression in Patients with Oral Squamous Cell Carcinoma.

Okamoto A, Sakakura K, Takahashi H, Motegi SI, Kaira K, Yokobori-Kuwabara Y, Ishikawa O, Chikamatsu K.

Pathol Oncol Res. 2019 Jun 29. doi: 10.1007/s12253-019-00692-3. [Epub ahead of print]

PMID:
31256324
4.

Tongue surface model can predict radiation tongue mucositis due to intensity-modulated radiation therapy for head and neck cancer.

Musha A, Fukata K, Saitoh JI, Shirai K, Abe T, Mizukami T, Kawashima M, Yokoo S, Chikamatsu K, Ohno T, Nakano T.

Int J Oral Maxillofac Surg. 2019 Jun 24. pii: S0901-5027(19)31188-9. doi: 10.1016/j.ijom.2019.06.012. [Epub ahead of print]

PMID:
31248705
5.

Evaluation of Q Gene Mycobacteria: A novel and easy nucleic acid chromatography method for mycobacterial species identification.

Chikamatsu K, Aono A, Kawai A, Hata H, Iwamoto T, Igarashi Y, Takaki A, Yamada H, Mitarai S.

J Microbiol Methods. 2019 Aug;163:105657. doi: 10.1016/j.mimet.2019.105657. Epub 2019 Jun 19.

PMID:
31228476
6.

Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma.

Takahashi H, Sakakura K, Arisaka Y, Tokue A, Kaira K, Tada H, Higuchi T, Okamoto A, Tsushima Y, Chikamatsu K.

Anticancer Res. 2019 Jun;39(6):3039-3046. doi: 10.21873/anticanres.13437.

PMID:
31177146
7.

A case of Mycobacterium tuberculosis laboratory cross-contamination.

Takeda K, Murase Y, Kawashima M, Suzukawa M, Suzuki J, Yamane A, Igarashi Y, Chikamatsu K, Morishige Y, Aono A, Yamada H, Takaki A, Tamura A, Nagai H, Matsui H, Tohma S, Mitarai S.

J Infect Chemother. 2019 Aug;25(8):610-614. doi: 10.1016/j.jiac.2019.03.012. Epub 2019 Apr 11.

PMID:
30982725
8.

Expression of immune-regulatory molecules in circulating tumor cells derived from patients with head and neck squamous cell carcinoma.

Chikamatsu K, Tada H, Takahashi H, Kuwabara-Yokobori Y, Ishii H, Ida S, Shino M.

Oral Oncol. 2019 Feb;89:34-39. doi: 10.1016/j.oraloncology.2018.12.002. Epub 2018 Dec 17.

PMID:
30732956
9.

Prognostic significance and population dynamics of peripheral monocytes in patients with oropharyngeal squamous cell carcinoma.

Takahashi H, Sakakura K, Tada H, Kaira K, Oyama T, Chikamatsu K.

Head Neck. 2019 Jun;41(6):1880-1888. doi: 10.1002/hed.25625. Epub 2019 Jan 12.

PMID:
30636187
10.

Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae.

Aono A, Morimoto K, Chikamatsu K, Yamada H, Igarashi Y, Murase Y, Takaki A, Mitarai S.

J Infect Chemother. 2019 Feb;25(2):117-123. doi: 10.1016/j.jiac.2018.10.010. Epub 2018 Nov 14.

PMID:
30447882
11.

A simplified pyrazinamidase test for pyrazinamide drug susceptibility in Mycobacterium tuberculosis.

Aono A, Chikamatsu K, Yamada H, Igarashi Y, Murase Y, Takaki A, Mitarai S.

J Microbiol Methods. 2018 Nov;154:52-54. doi: 10.1016/j.mimet.2018.09.018. Epub 2018 Oct 11.

PMID:
30316980
12.

Mycolicibacterium smegmatis, Basonym Mycobacterium smegmatis, Expresses Morphological Phenotypes Much More Similar to Escherichia coli Than Mycobacterium tuberculosis in Quantitative Structome Analysis and CryoTEM Examination.

Yamada H, Yamaguchi M, Igarashi Y, Chikamatsu K, Aono A, Murase Y, Morishige Y, Takaki A, Chibana H, Mitarai S.

Front Microbiol. 2018 Sep 11;9:1992. doi: 10.3389/fmicb.2018.01992. eCollection 2018.

13.

Six species of nontuberculous mycobacteria carry non-identical 16S rRNA gene copies.

Takeda K, Chikamatsu K, Igarashi Y, Morishige Y, Murase Y, Aono A, Yamada H, Takaki A, Mitarai S.

J Microbiol Methods. 2018 Dec;155:34-36. doi: 10.1016/j.mimet.2018.08.012. Epub 2018 Aug 27.

PMID:
30165088
14.

Prevention of aerosol isolation of nontuberculous mycobacterium from the patient's bathroom.

Morimoto K, Aono A, Murase Y, Sekizuka T, Kurashima A, Takaki A, Sasaki Y, Igarashi Y, Chikamatsu K, Goto H, Yamada H, Kuroda M, Mitarai S.

ERJ Open Res. 2018 Jul 3;4(3). pii: 00150-2017. doi: 10.1183/23120541.00150-2017. eCollection 2018 Jul.

15.

Melanoma antigen family A4 protein produced by transgenic silkworms induces antitumor immune responses.

Motokawa Y, Kokubo M, Kuwabara N, Tatematsu KI, Sezutsu H, Takahashi H, Sakakura K, Chikamatsu K, Takeda S.

Exp Ther Med. 2018 Mar;15(3):2512-2518. doi: 10.3892/etm.2018.5703. Epub 2018 Jan 4.

16.

Establishment of Synergistic Chemoimmunotherapy for Head and Neck Cancer Using Peritumoral Immature Dendritic Cell Injections and Low-Dose Chemotherapies.

Ishii H, Chikamatsu K, Igarashi S, Takahashi H, Sakamoto K, Higuchi H, Tanaka S, Matsuoka T, Masuyama K.

Transl Oncol. 2018 Feb;11(1):132-139. doi: 10.1016/j.tranon.2017.11.006. Epub 2017 Dec 18.

17.

Evaluation of PyroMark Q24 pyrosequencing as a method for the identification of mycobacteria.

Chikamatsu K, Aono A, Hata H, Igarashi Y, Takaki A, Yamada H, Sakashita K, Mitarai S.

Diagn Microbiol Infect Dis. 2018 Jan;90(1):35-39. doi: 10.1016/j.diagmicrobio.2017.09.002. Epub 2017 Sep 15.

PMID:
29107416
18.

Prediction of Local Transmission of Mycobacterium tuberculosis Isolates of a Predominantly Beijing Lineage by Use of a Variable-Number Tandem-Repeat Typing Method Incorporating a Consensus Set of Hypervariable Loci.

Murase Y, Izumi K, Ohkado A, Aono A, Chikamatsu K, Yamada H, Igarashi Y, Takaki A, Mitarai S.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01016-17. doi: 10.1128/JCM.01016-17. Print 2018 Jan.

19.

Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.

Igarashi Y, Chikamatsu K, Aono A, Yi L, Yamada H, Takaki A, Mitarai S.

Diagn Microbiol Infect Dis. 2017 Dec;89(4):276-281. doi: 10.1016/j.diagmicrobio.2017.08.016. Epub 2017 Aug 25.

PMID:
28974394
20.

Dose-volume histogram analysis of brainstem necrosis in head and neck tumors treated using carbon-ion radiotherapy.

Shirai K, Fukata K, Adachi A, Saitoh JI, Musha A, Abe T, Kanai T, Kobayashi D, Shigeta Y, Yokoo S, Chikamatsu K, Ohno T, Nakano T.

Radiother Oncol. 2017 Oct;125(1):36-40. doi: 10.1016/j.radonc.2017.08.014. Epub 2017 Aug 31.

21.

Circulating tumor cells in patients with head and neck squamous cell carcinoma: Feasibility of detection and quantitation.

Kawada T, Takahashi H, Sakakura K, Ida S, Mito I, Toyoda M, Chikamatsu K.

Head Neck. 2017 Nov;39(11):2180-2186. doi: 10.1002/hed.24893. Epub 2017 Aug 17.

PMID:
28815839
22.

Prospective observational study of carbon-ion radiotherapy for non-squamous cell carcinoma of the head and neck.

Shirai K, Saitoh JI, Musha A, Abe T, Kobayashi D, Takahashi T, Tamaki T, Kawamura H, Takayasu Y, Shino M, Toyoda M, Takahashi K, Hirato J, Yokoo S, Chikamatsu K, Ohno T, Nakano T; Working Group on Head and Neck Tumors.

Cancer Sci. 2017 Oct;108(10):2039-2044. doi: 10.1111/cas.13325. Epub 2017 Aug 17.

23.

In vitro activity of sitafloxacin against Mycobacterium tuberculosis with gyrA/B mutations isolated in Japan.

Yi L, Aono A, Chikamatsu K, Igarashi Y, Yamada H, Takaki A, Mitarai S.

J Med Microbiol. 2017 Jun 9. doi: 10.1099/jmm.0.000493. [Epub ahead of print]

PMID:
28598311
24.

PirB regulates asymmetries in hippocampal circuitry.

Ukai H, Kawahara A, Hirayama K, Case MJ, Aino S, Miyabe M, Wakita K, Oogi R, Kasayuki M, Kawashima S, Sugimoto S, Chikamatsu K, Nitta N, Koga T, Shigemoto R, Takai T, Ito I.

PLoS One. 2017 Jun 8;12(6):e0179377. doi: 10.1371/journal.pone.0179377. eCollection 2017.

25.

[A Case Report of Acute Angioedema that Showed Dramatic Response to Administration of a C1-inactivator].

Tada H, Matsuyama T, Kudo T, Chikamatsu K.

Nihon Jibiinkoka Gakkai Kaiho. 2017 Mar;120(3):217-23. Japanese.

PMID:
30010306
26.

Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancer.

Saitoh JI, Shirai K, Imaeda M, Musha A, Abe T, Shino M, Takayasu Y, Takahashi K, Chikamatsu K, Nakano T.

Radiat Oncol. 2017 Feb 20;12(1):39. doi: 10.1186/s13014-016-0741-4.

27.

Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.

Takahashi H, Sakakura K, Kudo T, Toyoda M, Kaira K, Oyama T, Chikamatsu K.

Oncotarget. 2017 Jan 31;8(5):8633-8647. doi: 10.18632/oncotarget.14374.

28.

Clinical Outcomes of Definitive and Postoperative Radiotherapy for Stage I-IVB Hypopharyngeal Cancer.

Shirai K, Saitoh JI, Musha A, Abe T, Kobayashi D, Takakusagi Y, Takaysu Y, Shino M, Toyoda M, Takahashi K, Chikamatsu K, Ohno T, Nakano T.

Anticancer Res. 2016 Dec;36(12):6571-6578.

PMID:
27919985
29.

Impact of a Multidisciplinary Round Visit for the Management of Dysphagia Utilizing a Wi-Fi-Based Wireless Flexible Endoscopic Evaluation of Swallowing.

Sakakura K, Tazawa M, Otani N, Takagi M, Morita M, Kurosaki M, Chiyoda T, Kanai Y, Endo A, Murata T, Shino M, Yokobori Y, Shirakura K, Wada N, Chikamatsu K.

Ann Otol Rhinol Laryngol. 2017 Jan;126(1):47-53. Epub 2016 Oct 23.

PMID:
27913722
30.

A Case of Maxillary Arteriovenous Fistula Rupture Treated by Vascular Interventional Radiology.

Takahashi K, Soma M, Matsuyama T, Kudo T, Chikamatsu K.

Nihon Jibiinkoka Gakkai Kaiho. 2016 Dec;119(12):1516-22. Japanese.

PMID:
30035485
31.

Mycobacterium shigaense Causes Lymph Node and Cutaneous Lesions as Immune Reconstitution Syndrome in an AIDS Patient: The Third Case Report of a Novel Strain Non-tuberculous Mycobacterium.

Koizumi Y, Shimizu K, Shigeta M, Minamiguchi H, Hodohara K, Andoh A, Tanaka T, Chikamatsu K, Mitarai S, Mikamo H.

Intern Med. 2016;55(22):3375-3381. Epub 2016 Nov 15.

32.

Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma.

Okano Y, Satoh T, Horiguchi K, Toyoda M, Osaki A, Matsumoto S, Tomaru T, Nakajima Y, Ishii S, Ozawa A, Shibusawa N, Shimada T, Higuchi T, Chikamatsu K, Yamada M.

Endocr J. 2016 Oct 29;63(10):905-912. Epub 2016 Jul 20.

33.

[EXTERNAL QUALITY ASSESSMENT OF ANTI-TUBERCULOSIS DRUG SUSCEPTIBILITY TESTING FOR DIAGNOSING EXTENSIVELY DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS].

Mitarai S, Yamada H, Aono A, Chikamatsu K, Higuchi T, Igarashi Y, Takaki A.

Kekkaku. 2016 Nov;91(11-12):717-725. Japanese.

PMID:
30648375
34.

[SPECIFICITY EVALUATION OF TRCReady® MTB AND TRCReady® MAC FOR IDENTIFYING MYCOBACTERIUM TUBERCULOSIS COMPLEX, MYCOBACTERIUM AVIUM AND MYCOBACTERIUM INTRACELLULARE].

Chikamatsu K, Igarashi Y, Aono A, Yamada H, Takaki A, Mitarai S.

Kekkaku. 2016 Oct;91(10):623-629. Japanese.

PMID:
30646447
35.

Factors contribute to efficiency of specimen concentration of Mycobacterium tuberculosis by centrifugation and magnetic beads.

Yoshimatsu S, Kato-Matsumaru T, Aono A, Chikamatsu K, Yamada H, Mitarai S.

Int J Mycobacteriol. 2015 Sep;4(3):245-9. doi: 10.1016/j.ijmyco.2015.05.014. Epub 2015 Jun 25.

36.

Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan.

Yi L, Sasaki Y, Nagai H, Ishikawa S, Takamori M, Sakashita K, Saito T, Fukushima K, Igarashi Y, Aono A, Chikamatsu K, Yamada H, Takaki A, Mori T, Mitarai S.

Sci Rep. 2016 Jul 29;6:30617. doi: 10.1038/srep30617.

37.

[Sequential Chemoradiotherapy for Advanced Head and Neck Cancer: A Clinical Study with 33 Cases].

Takahashi K, Nakajima K, Murata T, Shino M, Nikkuni O, Toyoda M, Takayasu Y, Chikamatsu K.

Nihon Jibiinkoka Gakkai Kaiho. 2016 May;119(5):734-40. Japanese.

PMID:
27459819
38.

Successful Treatment of Peritoneal Dialysis-related Peritonitis due to Mycobacterium iranicum.

Inagaki K, Mizutani M, Nagahara Y, Asano M, Masamoto D, Sawada O, Aono A, Chikamatsu K, Mitarai S.

Intern Med. 2016;55(14):1929-31. doi: 10.2169/internalmedicine.55.5219. Epub 2016 Jul 15.

39.

Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment.

Sakakura K, Takahashi H, Kaira K, Toyoda M, Murata T, Ohnishi H, Oyama T, Chikamatsu K.

Lab Invest. 2016 Sep;96(9):994-1003. doi: 10.1038/labinvest.2016.70. Epub 2016 Jun 20.

40.

Decreasing expression of glucose-regulated protein GRP78/BiP as a significant prognostic predictor in patients with advanced laryngeal squamous cell carcinoma.

Kaira K, Toyoda M, Shimizu A, Imai H, Sakakura K, Nikkuni O, Suzuki M, Iijima M, Asao T, Chikamatsu K.

Head Neck. 2016 Oct;38(10):1539-44. doi: 10.1002/hed.24471. Epub 2016 Jun 17.

PMID:
27312568
41.

Expression of ER stress markers (GRP78/BiP and PERK) in patients with tongue cancer.

Kaira K, Toyoda M, Shimizu A, Mori K, Shino M, Sakakura K, Takayasu Y, Takahashi K, Oyama T, Asao T, Chikamatsu K.

Neoplasma. 2016;63(4):588-94. doi: 10.4149/neo_2016_412.

PMID:
27268922
42.

Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy.

Takahashi H, Sakakura K, Mito I, Ida S, Chikamatsu K.

Cancer Sci. 2016 Aug;107(8):1065-71. doi: 10.1111/cas.12976. Epub 2016 Jun 24.

43.

Six Cases of Pulmonary Mycobacterium shinjukuense Infection at a Single Hospital.

Takeda K, Ohshima N, Nagai H, Sato R, Ando T, Kusaka K, Kawashima M, Masuda K, Matsui H, Aono A, Chikamatsu K, Mitarai S, Ohta K.

Intern Med. 2016;55(7):787-91. doi: 10.2169/internalmedicine.55.5460. Epub 2016 Apr 1.

44.

Mycobacterium conceptionense Bloodstream Infection in a Patient with Advanced Gastric Carcinoma.

Yaita K, Matsunaga M, Tashiro N, Sakai Y, Masunaga K, Miyoshi H, Oshima K, Chikamatsu K, Takaki A, Mitarai S, Watanabe H.

Jpn J Infect Dis. 2017 Jan 24;70(1):92-95. doi: 10.7883/yoken.JJID.2015.626. Epub 2016 Mar 18.

45.

Prognostic significance of GRP78/BiP expression in patients with Stage III/IV hypopharyngeal squamous cell carcinoma.

Kaira K, Toyoda M, Shimizu A, Imai H, Sakakura K, Nikkuni O, Suzuki M, Iijima M, Asao T, Chikamatsu K.

Neoplasma. 2016;63(3):477-83. doi: 10.4149/319_151002N513.

PMID:
26952514
46.

Oxygen-glucose deprivation increases firing of unipolar brush cells and enhances spontaneous EPSCs in Purkinje cells in the vestibulo-cerebellum.

Takayasu Y, Shino M, Nikkuni O, Yoshida Y, Furuya N, Chikamatsu K.

Neurosci Res. 2016 May;106:1-11. doi: 10.1016/j.neures.2015.10.009. Epub 2015 Nov 1.

PMID:
26535811
47.

COBAS® TaqMan® MTB, smear positivity grade and MGIT culture; correlation analyses of three methods for bacillary quantification.

Chikamatsu K, Aono A, Kato T, Takaki A, Yamada H, Sasaki Y, Izumi K, Yi L, Mitarai S.

J Infect Chemother. 2016 Jan;22(1):19-23. doi: 10.1016/j.jiac.2015.09.005. Epub 2015 Oct 31.

PMID:
26527538
48.

Extranodal soft tissue Rosai-Dorfman disease of the head and neck and its diagnostic difficulty.

Yajima M, Nakajima K, Hirato J, Chikamatsu K.

Auris Nasus Larynx. 2016 Jun;43(3):345-9. doi: 10.1016/j.anl.2015.09.008. Epub 2015 Nov 11.

PMID:
26526642
49.

Prediction of Acute Radiation Mucositis using an Oral Mucosal Dose Surface Model in Carbon Ion Radiotherapy for Head and Neck Tumors.

Musha A, Shimada H, Shirai K, Saitoh J, Yokoo S, Chikamatsu K, Ohno T, Nakano T.

PLoS One. 2015 Oct 29;10(10):e0141734. doi: 10.1371/journal.pone.0141734. eCollection 2015.

50.

Expression of ER stress markers (GRP78/BiP and PERK) in adenoid cystic carcinoma.

Kaira K, Toyoda M, Shimizu A, Shino M, Sakakura K, Takayasu Y, Takahashi K, Asao T, Chikamatsu K.

Acta Otolaryngol. 2016;136(1):1-7. doi: 10.3109/00016489.2015.1083120. Epub 2015 Sep 14.

PMID:
26366837

Supplemental Content

Loading ...
Support Center